From Targets to Treatments: Bridging Autoimmune Research to Advance Understanding of Alopecia Areata

0Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Alopecia areata is a common autoimmune skin disease resulting in the loss of hair on the scalp and elsewhere on the body that affects over 146 million people worldwide at some point in their lives. Founded in 1981, the National Alopecia Areata Foundation (NAAF) is a nonprofit organization that supports research to find a cure or acceptable treatment for alopecia areata, supports those with the disease, and educates the public about alopecia areata. NAAF conducts research summits every 2 years that are central to achieving the goals of a major strategic initiative, the Alopecia Areata Treatment Development Program, which are: to accelerate progress toward a safe, effective, affordable treatment or a cure for alopecia areata. These summits have played a key role in transforming the understanding of alopecia areata from largely inflammatory and dermatological perspectives to a focus on the genetic and immunological factors that are now recognized as driving and active determinants of the disease process.

Cite

CITATION STYLE

APA

Kranz, D., Ellison, A., Frelinger, J. A., Mackay-Wiggan, J., & Norris, D. A. (2015, November 1). From Targets to Treatments: Bridging Autoimmune Research to Advance Understanding of Alopecia Areata. Journal of Investigative Dermatology Symposium Proceedings. Nature Publishing Group. https://doi.org/10.1038/jidsymp.2015.29

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free